0A77.LSE Cigna Corp.
- Market cap
- -
- P/E
- 18.4x
- P/B
- -
- ROE
- -
- Dividend yield
- 1.87%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is 0A77.LSE undervalued?
Graham numberThe Graham number of Cigna Corp. cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cigna Corp. fundamental analysis
No fundamental analysis for Cigna Corp. yet.
Cigna Corp. stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cigna Corp.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formu…
Full company profileCigna Corp. financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cigna Corp. annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Operating Income | 2.98B | 3.86B | 3.85B | 8.25B | 12.3B | - | - | - |
| Net Income | 1.87B | 2.24B | 2.64B | 5.10B | 8.46B | - | - | - |
| Balance Sheet | ||||||||
| Total Assets | 59.4B | 61.8B | 153B | 156B | 155B | - | - | - |
| Total Liabilities | 45.6B | 48.0B | 112B | 110B | 105B | - | - | - |
| Shareholders' Equity | 13.7B | 13.7B | 41.0B | 45.3B | 50.3B | - | - | - |
| Cash & Short-term Investments | 3.19B | 2.97B | 3.86B | 4.62B | 10.2B | - | - | - |
| Total Debt | 4.76B | 5.20B | 39.5B | 31.9B | 29.5B | - | - | - |
| Cash Flow | ||||||||
| Operating Cash Flow | 4.03B | 4.09B | 3.77B | 9.49B | 10.4B | 7.19B | 8.66B | - |
| Capital Expenditure | 461M | 471M | 528M | 1.05B | 1.09B | 1.15B | 1.30B | 0.00 |
| Ratios | ||||||||
| ROE | 13.6% | 16.3% | 6.4% | 11.3% | 16.8% | - | - | - |
| ROA | 3.1% | 3.6% | 1.7% | 3.3% | 5.4% | - | - | - |
| Debt to Equity | 0.35x | 0.38x | 0.96x | 0.70x | 0.59x | - | - | - |
What these items mean
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cigna Corp. dividends
Cigna Corp. has not paid dividends in the last 9 fiscal years.
Who owns Cigna Corp.
- Insiders 1.44%
- Institutions 92.17%
- Public & others 6.38%
- Free float 263M
Cigna Corp. company profile
- Company name
- Cigna Corp.
- Ticker
- 0A77.LSE
- Exchange
- London Exchange
- Sector
- Healthcare
- Industry
- Commercial Services & Supplies
- Employees
- 65,669
- Fiscal year end
- December
- Address
- 900 Cottage Grove Road, Bloomfield, CT, United States, 06002
- Phone
- 860 226 6000
- Website
- thecignagroup.com
About Cigna Corp.
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. It operates through two segments: Evernorth Health Services and Cigna Healthcare. The Evernorth Health Services segment includes Pharmacy Benefit Services and Specialty and Care Services, offering pharmacy benefit management, drug claim adjudication, retail pharmacy network administration, benefit design consultation, drug utilization review, drug formulary management, pharmacy benefits, home delivery pharmacy, specialty pharmacy, specialty pharmaceutical distribution, and clinical programs for whole-person health outcomes. The Cigna Healthcare segment comprises U.S. Healthcare and International Health, delivering comprehensive medical and coordinated solutions such as employer medical plans, individual and family plans, behavioral health, consumer health engagement, dental, pharmacy management, stop-loss insurance, global health care, and local health care solutions, as well as health care benefits for mobile individuals and employees of multinational organizations. The company offers other operations, including corporate-owned life insurance, reinsurance, and certain run-off and non-strategic businesses. The company distributes its products and services through brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The company was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Cigna Corp. management
10- Mr. David Michael CordaniExecutive Chairman of the Board · born 1965
- Mr. Brian Case Evanko C.F.A.President, CEO & Director · born 1977
- Ms. Ann M. DennisonExecutive VP & CFO · born 1971
- Ms. Nicole Susan Jones J.D.Executive Vice President, Chief Administrative Officer & Chief Human Resources Officer · born 1971
- Mr. F. Everett NevilleExecutive VP & Special Advisor to the CEO · born 1965
- Ms. Jamie KatesSenior VP & Tax and Global Chief Accounting Officer · born 1980
- Mr. Durga Prasad KokaExecutive Vice President & Global Chief Information Officer
- Mr. Ralph GiacobbeSenior Vice President of Investor Relations
- Ms. Andrea NelsonEVP, General Counsel & Corporate Secretary
- Ms. Melissa SkottegaardExecutive Vice President, Chief Marketing & Communications Officer